AzTrials
AzTrials

Gingival RecessionNCT04980066

Evaluation of Sticky Bone With or Without EDTA for Treatment of Gingival Recession

A study testing Sticky bone and EDTA and Sticky bone in people with Gingival Recession, run by Kafrelsheikh University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Gingival recession is a common clinical finding in periodontal disease which is frequently associated with esthetic concerns, root hypersensitivity, and root caries. Many surgical therapeutic approaches have been developed to predictably obtain root coverage of gingival recession defects. Read more about this study

Who is it for?
Ages 18 to 70 yearsHealthy volunteers can take part
Conditions the study is for
Gingival Recession
What is being tested?
Sticky bone and EDTA and Sticky bone
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteEgypt
Study dates
3 Aug 2021to Sep 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Miller I/II isolated maxillary recession defects.
  • No abrasion, caries, or cervical restorations and presence of identifiable cementoenamel junction (CEJ).
  • No occlusal interferences.
  • Full-mouth plaque index (PI) and gingival index (GI) scores of < 1.
  • Non-smokers.

Who cannot join

  • Pregnant patients
  • Presence of systemic disease or taking medication that interfere with periodontium

Trial locations and contacts

1 site in 1 country.

Egypt1 site, 1 recruiting
  • Faculty of Dentistry, Kafrelsheikh University

    Kafr ash Shaykh, Kafr el-Sheikh Governorate, 33511

    Dalia R Issa, PhD, 01007753636 ext. 002, dalia_rasheed@hotmail.com

    Recruiting

Other trials in Egypt

About this study

Official title: Evaluation of Sticky Bone With or Without EDTA Root Surface Biomodification for Treatment of Gingival Recession: Randomized Controlled Clinical Study

Gingival recession is a common clinical finding in periodontal disease which is frequently associated with esthetic concerns, root hypersensitivity, and root caries. Many surgical therapeutic approaches have been developed to predictably obtain root coverage of gingival recession defects. Injectable PRF (I-PRF) is the liquid form of PRF. I-PRF is a bioactive agent obtained by low-speed centrifugation, and it has the capacity to stimulate tissue regeneration. At high concentrations, PRF may stimulate the secretion of several growth factors and trigger fibroblast migration. I-PRF is generally used in regenerative treatments, with good outcomes. Ethylenediaminetetraaceti acid (EDTA) is a chelating agent that could enhance the attachment of connective tissue to the root surface by exposing collagen and, as a consequence, enhance root coverage. EDTA works at neutral pH, and this property has been reported to preserve adjacent tissue vitality. The present study will be carried out to evaluate the effect of sticky bone with or without EDTA root surface biomodification for treatment of gingival recession.

Being tested
Sticky bone and EDTA, Sticky bone
Keywords
i-PRF, EDTA
Medical subject headings
Gingival Recession

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Sticky bone and EDTAProcedure or surgery

    treatment using Sticky bone after EDTA root surface biomodification

  • Sticky boneProcedure or surgery

    treatment using Sticky bone

Study groups in NCT04980066
Study groupRoleWhat they receive
sticky bone and EDTAExperimentaltreatment of gingival recession using sticky bone after root surface biomodification with EDTA
Receives: Procedure: Sticky bone and EDTA
Sticky boneActive comparatortreatment of gingival recession using sticky bone
Receives: Procedure: Sticky bone

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. clinical evaluation of root coverage

    the percentage of root coverage will be calculated in millimeter

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Jul 2021
  2. Study start3 Aug 2021
  3. Primary completionAug 2024 (estimated)
  4. Study completionSep 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Care provider
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04980066
Sponsor's protocol ID
KD/10/21
Status last verified
Apr 2024
First submitted
24 Jun 2021
Last updated
11 Apr 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Sticky bone and EDTA and Sticky bone in people with Gingival Recession, run by Kafrelsheikh University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 11 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Dalia R Issa, PhD (01007753636 ext. 002, dalia_rasheed@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

clinical evaluation of root coverage (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Apr 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in